Image de couverture de livre

Net prices of new antiobesity medications

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Inmaculada Hernandez, Sean D. Sullivan
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Obesity
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Nutritional considerations with antiobesity medications
par: Jaime P. Almandoz, et autres
Publié: (2024)

Response to “Nutritional considerations with antiobesity medications”
par: Shaminie J. Athinarayanan
Publié: (2024)

Response to “Nutritional considerations with antiobesity medications”
par: Gabriela de Souza Bett, et autres
Publié: (2024)

Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
par: Jamy D. Ard, et autres
Publié: (2024)

Adverse event comparison between glucagon‐like peptide‐1 receptor agonists and other antiobesity medications following bariatric surgery
par: Jason M. Samuels, et autres
Publié: (2024)

Meta‐analysis and machine learning reveal the antiobesity effects of melatonin on obese rodents
par: Yuying Li, et autres
Publié: (2024)

Managing the new wave of weight loss medication in general practice: A qualitative study
par: Pernille Andreassen, et autres
Publié: (2024)

Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills
par: Hamlet Gasoyan, et autres
Publié: (2024)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
par: Sheila Pintado-Cucarella
Publié: (2016)

Antiobesity medications in active‐duty military personnel
par: Brandon M. Roberts, et autres
Publié: (2024)

The association between weight loss medications and cardiovascular complications
par: Onur Baser, et autres
Publié: (2024)

Less frequent dosing of GLP‐1 receptor agonists as a viable weight maintenance strategy
par: Calvin C. Wu, et autres
Publié: (2025)

The vices and virtues of medical models of obesity
par: Jonathan Sholl, et autres
Publié: (2024)

Obesity and postpartum hospital use among individuals without additional medical comorbidities
par: Kimberly B. Glazer, et autres
Publié: (2024)

Weight management medications for chronic use in 37 veterans affairs medical centers—A medication use evaluation
par: Samantha Walczuk, et autres
Publié: (2024)

Measurement and evaluation of community engagement in complex, chronic medical conditions: HIV and obesity as exemplar conditions
par: Andrew D. Brown, et autres
Publié: (2025)

Determinants of adherence to obesity medication: A narrative review
par: Arya M. Sharma, et autres
Publié: (2025)

Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
par: Lee M. Kaplan, et autres
Publié: (2025)

Primary care perspectives on prescribing anti‐obesity medication for adolescents
par: Rutha Chivate, et autres
Publié: (2024)

The effects of anti‐obesity medications on bone metabolism: A critical appraisal
par: Athanasios D. Anastasilakis, et autres
Publié: (2025)

Evaluation of prescription medication changes following sleeve gastrectomy surgery
par: Gina Arena, et autres
Publié: (2024)

Global deletion of G protein‐coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β‐cell turnover
par: Bo Liu, et autres
Publié: (2024)

Enfoque de la obesidad infantil desde la pediatría
par: Erika F. Hurtado-López
Publié: (2014)

Cost‐utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide
par: Shanshan Hu, et autres
Publié: (2024)

Incretin mimetics for weight loss forgive nonadherence
par: Anıl Cengiz, et autres
Publié: (2025)

Correction to “Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time”
Publié: (2024)

Ethnic differences in weight loss during a clinical obesity management program
par: Jennifer Linchee Kuk, et autres
Publié: (2025)

The association of weight loss from anti‐obesity medications or bariatric surgery and apnea‐hypopnea index in obstructive sleep apnea
par: Brian W. Locke, et autres
Publié: (2024)

Associations of BMI, sleep quality, and sleep duration trajectories with new‐onset diabetes mellitus in the elderly
par: Shanshan Li, et autres
Publié: (2025)

What is known about the use of weight loss medication in women with overweight/obesity on fertility and reproductive health outcomes? A scoping review
par: Kate Maslin, et autres
Publié: (2024)

Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes
par: Stephanie A. Hooker, et autres
Publié: (2026)

Cardiometabolic risk effects of weight‐loss medications: An updated network meta‐analysis
par: Juan Wang, et autres
Publié: (2025)

Four‐year follow‐up of weight loss maintenance using electronic medical record data: The PROPEL trial
par: Peter T. Katzmarzyk, et autres
Publié: (2024)

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN
par: Deborah B. Horn, et autres
Publié: (2025)

Antidiabetic and lipid‐lowering medication use inversely linked with serum biomarkers of liver fibrosis
par: Jun Wang, et autres
Publié: (2025)

The real‐world relationship between naltrexone/bupropion treatment and weight loss in Canada: A retrospective chart review
par: Sean Wharton, et autres
Publié: (2024)

Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
par: Crystal M. Y. Lee, et autres
Publié: (2025)

Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2)
par: Sean Wharton, et autres
Publié: (2024)

Weight status of children and adolescents with autism spectrum disorder: A cross‐sectional analysis of primary care electronic medical records and linked health administrative datasets in Ontario, Canada
par: Laura M. Kinlin, et autres
Publié: (2025)

The association of motivational factors with weight loss and treatment time in a publicly funded weight management clinic
par: Amir Yazdanparast, et autres
Publié: (2025)